The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this method offers a more convenient way to provide https://denisftgr948338.jaiblogs.com/68040269/glp-1-patches-a-innovative-approach-to-blood-sugar-treatment